These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11267967)

  • 1. Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes.
    Nomura T; Hasegawa H; Kohno M; Sasaki M; Fujita S
    Int J Cancer; 2001 Mar; 91(5):597-606. PubMed ID: 11267967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo.
    Sharma S; Stolina M; Luo J; Strieter RM; Burdick M; Zhu LX; Batra RK; Dubinett SM
    J Immunol; 2000 May; 164(9):4558-63. PubMed ID: 10779757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
    Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
    J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model.
    Hillinger S; Yang SC; Zhu L; Huang M; Duckett R; Atianzar K; Batra RK; Strieter RM; Dubinett SM; Sharma S
    J Immunol; 2003 Dec; 171(12):6457-65. PubMed ID: 14662845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of IL-7, stromal-derived factor-1 alpha, thymus-expressed chemokine, and secondary lymphoid tissue chemokine gene expression in the stromal cells in response to thymocyte depletion: implication for thymus reconstitution.
    Zubkova I; Mostowski H; Zaitseva M
    J Immunol; 2005 Aug; 175(4):2321-30. PubMed ID: 16081802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation.
    Nakano H; Gunn MD
    J Immunol; 2001 Jan; 166(1):361-9. PubMed ID: 11123313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines.
    Ansel KM; McHeyzer-Williams LJ; Ngo VN; McHeyzer-Williams MG; Cyster JG
    J Exp Med; 1999 Oct; 190(8):1123-34. PubMed ID: 10523610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7.
    Campbell JJ; Bowman EP; Murphy K; Youngman KR; Siani MA; Thompson DA; Wu L; Zlotnik A; Butcher EC
    J Cell Biol; 1998 May; 141(4):1053-9. PubMed ID: 9585422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation-dependent modulation of B lymphocyte migration to chemokines.
    Brandes M; Legler DF; Spoerri B; Schaerli P; Moser B
    Int Immunol; 2000 Sep; 12(9):1285-92. PubMed ID: 10967023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse.
    Luther SA; Tang HL; Hyman PL; Farr AG; Cyster JG
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12694-9. PubMed ID: 11070085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon gamma-independent rejection of interleukin 12-transduced carcinoma cells requires CD4+ T cells and Granulocyte/Macrophage colony-stimulating factor.
    Zilocchi C; Stoppacciaro A; Chiodoni C; Parenza M; Terrazzini N; Colombo MP
    J Exp Med; 1998 Jul; 188(1):133-43. PubMed ID: 9653090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
    Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
    J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease.
    Kawashima D; Oshitani N; Jinno Y; Watanabe K; Nakamura S; Higuchi K; Arakawa T
    J Clin Pathol; 2005 Oct; 58(10):1057-63. PubMed ID: 16189151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT.
    Hisada M; Yoshimoto T; Kamiya S; Magami Y; Miyaji H; Yoneto T; Tamada K; Aoki T; Koyanagi Y; Mizuguchi J
    Cancer Gene Ther; 2004 Apr; 11(4):280-8. PubMed ID: 15002032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
    Flanagan K; Glover RT; Hörig H; Yang W; Kaufman HL
    Vaccine; 2004 Jul; 22(21-22):2894-903. PubMed ID: 15246626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells.
    Braun SE; Chen K; Foster RG; Kim CH; Hromas R; Kaplan MH; Broxmeyer HE; Cornetta K
    J Immunol; 2000 Apr; 164(8):4025-31. PubMed ID: 10754294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms.
    Vicari AP; Ait-Yahia S; Chemin K; Mueller A; Zlotnik A; Caux C
    J Immunol; 2000 Aug; 165(4):1992-2000. PubMed ID: 10925282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines and anti-cancer immunotherapy: anti-tumor effect of EBI1-ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC).
    Nomura T; Hasegawa H
    Anticancer Res; 2000; 20(6A):4073-80. PubMed ID: 11131675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.